Search research articles
Contact Us
Filters
Showing results (261-270 of 388) with videos related to
Page
of 39
Sort By:
Thorax
|
October 1, 1975
Survey of the sputum cytology service in England and Wales
N C Oswald, K F Hinson, G Canti, et al.
The Journal of Biological Chemistry
|
August 15, 2003
ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux
Nan Wang, Debin Lan, Marie Gerbod-Giannone, et al.
The Journal of Clinical Investigation
|
August 30, 2005
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Reeba K Vikramadithyan, Yunying Hu, Hye-Lim Noh, et al.
Atherosclerosis
|
October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency
J Koizumi, A Inazu, K Yagi, et al.
Lancet (London, England)
|
February 12, 1972
Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis
G A Ellard, P T Gammon, S Lakshminarayan, et al.
Circulation Research
|
December 15, 2010
Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling
Tamara A Pagler, Mi Wang, Mousumi Mondal, et al.
The Journal of Clinical Investigation
|
September 1, 1993
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice
T Hayek, N Azrolan, R B Verdery, et al.
The Journal of Biological Chemistry
|
June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
L B Agellon, A Walsh, T Hayek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 16, 2000
Plasma sphingomyelin level as a risk factor for coronary artery disease
X C Jiang, F Paultre, T A Pearson, et al.
Tubercle
|
March 1, 1974
A study of adverse reactions to high dosage intermittent thiacetazone
W Fox, A J Stark, R Tall, et al.
Page
of 39
Search research articles
Search
Showing results (261-270 of 388) with videos related to
Sort By:
Page
of 39
Thorax
|
October 1, 1975
Survey of the sputum cytology service in England and Wales
N C Oswald, K F Hinson, G Canti, et al.
The Journal of Biological Chemistry
|
August 15, 2003
ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux
Nan Wang, Debin Lan, Marie Gerbod-Giannone, et al.
The Journal of Clinical Investigation
|
August 30, 2005
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Reeba K Vikramadithyan, Yunying Hu, Hye-Lim Noh, et al.
Atherosclerosis
|
October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency
J Koizumi, A Inazu, K Yagi, et al.
Lancet (London, England)
|
February 12, 1972
Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis
G A Ellard, P T Gammon, S Lakshminarayan, et al.
Circulation Research
|
December 15, 2010
Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling
Tamara A Pagler, Mi Wang, Mousumi Mondal, et al.
The Journal of Clinical Investigation
|
September 1, 1993
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice
T Hayek, N Azrolan, R B Verdery, et al.
The Journal of Biological Chemistry
|
June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
L B Agellon, A Walsh, T Hayek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 16, 2000
Plasma sphingomyelin level as a risk factor for coronary artery disease
X C Jiang, F Paultre, T A Pearson, et al.
Tubercle
|
March 1, 1974
A study of adverse reactions to high dosage intermittent thiacetazone
W Fox, A J Stark, R Tall, et al.
Page
of 39